Question

In: Statistics and Probability

"You have developed a new anti-anxiety drug and are interested in its efficacy. You have two...

"You have developed a new anti-anxiety drug and are interested in its efficacy. You have two groups of rats (N=20 per group). You inject the one group (group 0) with saline, and inject the other group (group 1) with your anti-anxiety drug. Your outcome variable is the amount of exploratory behaviour (‘locomotion’) measured in a novel environment (a mild stress) over 1 hour. "

I ran an independent-samples t-test in SPSS (a statistics program) on this data and the same test but with bootstrapping.

Somehow the results were that the data is insignificant with a p-value of 0.139, alpha of 0.05, but the 95% confidence interval was 6.967 - 61.128.

If the data is insignificant, should 0 not be a value within the 95% confidence interval?

How is it possible that the null value (0) is not within the confidence interval, but still have a rather large insignificant result?

Solutions

Expert Solution

Here we have p value is 0.139

Alpha value is 95% level of significance that is 0.05

Here we can use p value approach we reject Ho if p value is less than alpha value. That is result is significant if p value is less than alpha value.

Our result p value is greater than alpha value here result is not significant at given level.

Here we have confidence interval : we can do results from confidence interval also

If interval include null value result is not significant.

Here interval is 6.967 - 61.128

That is interval not include zero or null value hence result is significant.

p value approach gives not significant and confidence interval gives the significant result.

## Note :

Some time our result is significant by p value approach but confidence interval include null value or vice versa.

Here p value approach is preferred rather than confidence interval.

And statistician and researchers believe in p value approach rather than confidence interval.

Hence here result is not significant.


Related Solutions

In a study to evaluate drug efficacy, the manufacturer of a new type of generic drug...
In a study to evaluate drug efficacy, the manufacturer of a new type of generic drug for treating a disease wants to investigate the effectiveness of this generic drug as compared to the traditional brand name drug, At the present time, the brand name drug is the only approved treatment for the disease. Patients diagnosed with the disease have low concentration of a specific factor in their blood. Treatment with the brand name drug will result in an increase in...
You are interested in the Food and Drug Administration and its most recent new role of...
You are interested in the Food and Drug Administration and its most recent new role of oversight of e-cigarettes. Many of your friends use e-cigarettes and you are not sure if they are a healthy alternative to cigarettes. Activity: Perform an internet search of the FDA and its regulation of e-cigarettes and the health implications of e-cigarettes, and present your findings to the class.
Sharpe Pharmaceuticals has developed a new drug called Zantor that can cure anxiety disorders. Sharpe Pharmaceuticals...
Sharpe Pharmaceuticals has developed a new drug called Zantor that can cure anxiety disorders. Sharpe Pharmaceuticals has a patent on the production of Zantor. Suppose the demand Zantor is given by the equation P=86-1/3000Q and the marginal revenue is given by the equation MR=86-1/1500Q. Further suppose that the marginal cost of producing Zantor is MC=6 and the average total cost is given by the formula: ATC=100,000/Q+6 Calculate the profit-maximizing price and quantity. How much profit does Sharpe Pharmaceuticals earn? One...
A randomized clinical trial was designed to test the efficacy of a new serotonin-reuptake inhibitor (anxiety...
A randomized clinical trial was designed to test the efficacy of a new serotonin-reuptake inhibitor (anxiety reducing drug – ARD) to treat the symptoms of anxiety compared to a more traditional approach of behavioral therapy. The trial randomized 1,200 men and women with untreated anxiety symptoms in a 1:1 ratio to either 1) treatment with ARD, and 2) weekly behavioral therapy sessions. The primary endpoint was resolution of anxiety based on results from a validated anxiety assessment instrument. At six...
A clinical trial is run to look at the efficacy of a new blood pressure drug....
A clinical trial is run to look at the efficacy of a new blood pressure drug. Patients with a diagnosis of hypertension (high blood pressure) are recruited to participate in the trial and randomized to receive either the new drug or placebo. Participants take the assigned drug for 12 weeks and their blood pressure status is recorded. At the end of the trial, participants are classified as still having hypertension or not. The data are shown here: Group Number with...
2. A clinical trial is conducted to evaluate the efficacy of a new drug for prevention...
2. A clinical trial is conducted to evaluate the efficacy of a new drug for prevention of hypertension in patients with pre-hypertension (defined as systolic blood pressure between 120–139 mmHg or diastolic blood pressure between 80–89 mmHg). A total of 20 patients are randomized to receive the new drug or a currently available drug for treatment of high blood pressure. Participants are followed for up to 12 months, and time to progression to hypertension is measured. The experiences of participants...
A clinical trial is being conducted in order to determine the efficacy of a new drug...
A clinical trial is being conducted in order to determine the efficacy of a new drug that will be used to treat type II diabetes. The efficacy of the medication will be determined by the blood glucose readings obtained from the patients. If the researcher wants a margin of error less than or equal to 5 mg/dL and the standard deviation for blood glucose readings among type II diabetics was previous documented as 15 mg/dL, how many patients should be...
The efficacy of a drug is dependent on a therapeutic concentration reaching its target site of...
The efficacy of a drug is dependent on a therapeutic concentration reaching its target site of action. If the too little drug is present there may be no therapeutic benefit, too much and over-dosage might occur. Describe in detail the pharmacodynamic and pharmacokinetic properties that need to be ascertained in order to use a drug properly. Your answer should include how these properties can be determined, why they are important to the functioning of a particular drug and what might...
A team of researchers have developed a new weight loss drug. They want to know if...
A team of researchers have developed a new weight loss drug. They want to know if patients who use the new drug for two weeks lose any weight. The drug has some minor side effects including mild headaches and achiness. If the researchers obtain evidence of weight loss they will proceed to produce the drug commercially and sell it for a large profit. If they do not obtain evidence of weight loss they will end the project. [70 points] What...
You work for a pharmaceutical company that has developed a new drug. The patent on the...
You work for a pharmaceutical company that has developed a new drug. The patent on the drug will last for 17 years. You expect that the drug's profits will be 4 million in its first year and that this amount will grow at a rate of 6% per year for the next 16 years. Once the patent expires, other pharmaceutical companies will be able to produce the same drug and competition will likely drive profits to zero. I f the...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT